These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 12654968)
41. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. Sobti RC; Kaur P; Kaur S; Janmeja AK; Jindal SK; Kishan J; Raimondi S DNA Cell Biol; 2009 Sep; 28(9):443-9. PubMed ID: 19558213 [TBL] [Abstract][Full Text] [Related]
42. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Lin HJ; Han CY; Lin BK; Hardy S Pharmacogenetics; 1994 Jun; 4(3):125-34. PubMed ID: 7920692 [TBL] [Abstract][Full Text] [Related]
43. Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population. Lu L; Tao B; Wei H; Chen H; He X; Pan H; Yang M; Yi H; Tang S J Gene Med; 2019 Jun; 21(6):e3096. PubMed ID: 31066138 [TBL] [Abstract][Full Text] [Related]
44. Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease. Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Molina JA; Ortí-Pareja M; Vázquez A; Ramos F; Duarte J; Coria F; Ladero JM; Alvarez-Cermeño JC; Benítez J Neurology; 1998 Dec; 51(6):1587-92. PubMed ID: 9855506 [TBL] [Abstract][Full Text] [Related]
45. NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese. Inatomi H; Katoh T; Kawamoto T; Matsumoto T Int J Urol; 1999 Sep; 6(9):446-54. PubMed ID: 10510890 [TBL] [Abstract][Full Text] [Related]
46. Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population. Vilčková M; Jurečeková J; Dobrota D; Habalová V; Klimčáková L; Waczulíková I; Slezák P; Kliment J; Sivoňová MK Med Oncol; 2014 Jun; 31(6):987. PubMed ID: 24816842 [TBL] [Abstract][Full Text] [Related]
47. N-acetyltransferase 2 polymorphism and acetylation profiles in Buginese ethnics of Indonesia. Yuliwulandari R; Susilowati RW; Razari I; Viyati K; Umniyati H; Prayuni K Ann Hum Genet; 2019 Nov; 83(6):465-471. PubMed ID: 31332782 [TBL] [Abstract][Full Text] [Related]
48. N-Acetyltransferase 2 (NAT2) genetic variation and the susceptibility to noncardiac gastric adenocarcinoma in Taiwan. Chang CH; Huang YS; Perng CL; Lin HC J Chin Med Assoc; 2016 Mar; 79(3):105-10. PubMed ID: 26617241 [TBL] [Abstract][Full Text] [Related]
49. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632 [TBL] [Abstract][Full Text] [Related]
50. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396 [TBL] [Abstract][Full Text] [Related]
51. A rapid method of screening for N-acetyltransferase (NAT2) phenotype by use of the WAVE DNA fragment analysis system. Osborne A; Bell C; Grant F; Dick F; Seaton A; Haites N Biochem Genet; 2003 Dec; 41(11-12):405-11. PubMed ID: 14994828 [TBL] [Abstract][Full Text] [Related]
52. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk. Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715 [TBL] [Abstract][Full Text] [Related]
53. Genetic polymorphisms of N-acetyltransferase 2 and colorectal cancer risk. He LJ; Yu YM; Qiao F; Liu JS; Sun XF; Jiang LL World J Gastroenterol; 2005 Jul; 11(27):4268-71. PubMed ID: 16015704 [TBL] [Abstract][Full Text] [Related]
54. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility. Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403 [TBL] [Abstract][Full Text] [Related]
55. A slow acetylator genotype associated with an increased risk of advanced cervical cancer. Costa S; Medeiros R; Vasconcelos A; Pinto D; Lopes C J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054 [TBL] [Abstract][Full Text] [Related]
56. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population. Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937 [TBL] [Abstract][Full Text] [Related]
57. Comparison of N-acetyltransferase-2 enzyme genotype-phenotype and xanthine oxidase enzyme activity between Swedes and Koreans. Djordjevic N; Carrillo JA; Roh HK; Karlsson S; Ueda N; Bertilsson L; Aklillu E J Clin Pharmacol; 2012 Oct; 52(10):1527-34. PubMed ID: 22105431 [TBL] [Abstract][Full Text] [Related]
58. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms. Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242 [TBL] [Abstract][Full Text] [Related]
59. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Deitz AC; Zheng W; Leff MA; Gross M; Wen WQ; Doll MA; Xiao GH; Folsom AR; Hein DW Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):905-10. PubMed ID: 11008907 [TBL] [Abstract][Full Text] [Related]